Check out the latest from Noxopharm CEO Dr Olivier Laczka as he outlines the significant potential of the company's technology platform: www.proactiveinvestors.com.au/companies/ne...
Noxopharm Limited CEO Olivier Laczka talked with Proactive about the company's Sofra™ technology platform and how its discovery around Toll-like...
